DAFNA Capital Management as of Sept. 30, 2025
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 75 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis Com New (STXS) | 10.5 | $43M | 14M | 3.11 | |
| Spdr S&p Biotech Etf Etf (XBI) | 9.9 | $40M | 402k | 100.20 | |
| Revolution Medicines (RVMD) | 7.6 | $31M | 657k | 46.70 | |
| Cytokinetics Com New (CYTK) | 5.4 | $22M | 395k | 54.96 | |
| AtriCure (ATRC) | 5.2 | $21M | 592k | 35.25 | |
| Merus N V (MRUS) | 5.1 | $21M | 221k | 94.15 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 3.7 | $15M | 103k | 144.37 | |
| Ideaya Biosciences (IDYA) | 3.6 | $15M | 540k | 27.21 | |
| Axogen (AXGN) | 3.3 | $13M | 742k | 17.84 | |
| Xenon Pharmaceuticals (XENE) | 2.9 | $12M | 288k | 40.15 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $9.9M | 71k | 140.38 | |
| Arcus Biosciences Incorporated (RCUS) | 2.1 | $8.5M | 628k | 13.60 | |
| Syndax Pharmaceuticals (SNDX) | 1.9 | $7.7M | 501k | 15.38 | |
| Day One Biopharmaceuticals I (DAWN) | 1.7 | $7.0M | 999k | 7.05 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.6 | $6.6M | 33k | 198.81 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.3 | $5.4M | 4.0M | 1.36 | |
| Kalvista Pharmaceuticals (KALV) | 1.3 | $5.1M | 423k | 12.18 | |
| Bicara Therapeutics (BCAX) | 1.2 | $5.0M | 317k | 15.79 | |
| Inogen (INGN) | 1.2 | $4.9M | 606k | 8.17 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.1 | $4.6M | 811k | 5.73 | |
| Galapagos Nv Spon Adr (GLPG) | 1.1 | $4.5M | 130k | 34.64 | |
| Dex (DXCM) | 1.1 | $4.4M | 66k | 67.29 | |
| Tandem Diabetes Care Com New (TNDM) | 1.1 | $4.3M | 355k | 12.14 | |
| Kura Oncology (KURA) | 1.0 | $4.1M | 463k | 8.85 | |
| Alkermes SHS (ALKS) | 1.0 | $4.0M | 135k | 30.00 | |
| Stoke Therapeutics (STOK) | 1.0 | $4.0M | 170k | 23.50 | |
| Soleno Therapeutics (SLNO) | 0.9 | $3.6M | 53k | 67.60 | |
| Biohaven (BHVN) | 0.9 | $3.5M | 235k | 15.01 | |
| Edgewise Therapeutics (EWTX) | 0.9 | $3.5M | 214k | 16.22 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.8 | $3.3M | 1.6M | 2.13 | |
| Larimar Therapeutics (LRMR) | 0.8 | $3.3M | 1.0M | 3.23 | |
| Compass Therapeutics (CMPX) | 0.8 | $3.3M | 947k | 3.50 | |
| Mineralys Therapeutics (MLYS) | 0.8 | $3.2M | 84k | 37.92 | |
| Nektar Therapeutics Com New (NKTR) | 0.8 | $3.1M | 55k | 56.90 | |
| Immunovant (IMVT) | 0.8 | $3.1M | 192k | 16.12 | |
| Korro Bio (KRRO) | 0.7 | $2.9M | 61k | 47.89 | |
| Aquestive Therapeutics (AQST) | 0.7 | $2.9M | 513k | 5.59 | |
| Denali Therapeutics (DNLI) | 0.6 | $2.4M | 169k | 14.52 | |
| Lexeo Therapeutics (LXEO) | 0.6 | $2.4M | 358k | 6.64 | |
| Alector (ALEC) | 0.6 | $2.4M | 798k | 2.96 | |
| Astria Therapeutics (ATXS) | 0.6 | $2.3M | 320k | 7.28 | |
| Rapport Therapeutics (RAPP) | 0.6 | $2.2M | 75k | 29.70 | |
| Tela Bio (TELA) | 0.5 | $2.1M | 1.4M | 1.49 | |
| Insulet Corporation (PODD) | 0.5 | $2.1M | 6.9k | 308.73 | |
| Mediwound Shs New (MDWD) | 0.5 | $2.0M | 114k | 18.02 | |
| Accuray Incorporated (ARAY) | 0.5 | $2.0M | 1.2M | 1.67 | |
| Immatics Nv SHS (IMTX) | 0.5 | $2.0M | 235k | 8.52 | |
| Allogene Therapeutics (ALLO) | 0.4 | $1.7M | 1.4M | 1.24 | |
| Viking Therapeutics (VKTX) | 0.4 | $1.7M | 65k | 26.28 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $1.7M | 218k | 7.59 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $1.7M | 59k | 28.00 | |
| Mbx Biosciences (MBX) | 0.4 | $1.5M | 85k | 17.50 | |
| Silverback Therapeutics (SPRY) | 0.3 | $1.4M | 141k | 10.05 | |
| Align Technology (ALGN) | 0.3 | $1.4M | 11k | 125.22 | |
| Keros Therapeutics (KROS) | 0.3 | $1.3M | 81k | 15.82 | |
| Inspire Med Sys (INSP) | 0.3 | $1.3M | 17k | 74.20 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $1.3M | 105k | 12.00 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $1.2M | 307k | 3.79 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.2 | $902k | 364k | 2.48 | |
| Brainsway Sponsored Ads (BWAY) | 0.2 | $859k | 57k | 15.07 | |
| Century Therapeutics (IPSC) | 0.2 | $849k | 1.7M | 0.50 | |
| Erasca (ERAS) | 0.2 | $763k | 350k | 2.18 | |
| Polypid (PYPD) | 0.2 | $693k | 208k | 3.33 | |
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $690k | 7.0k | 98.62 | |
| Celldex Therapeutics Com New (CLDX) | 0.2 | $634k | 25k | 25.87 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $620k | 127k | 4.89 | |
| Urogen Pharma (URGN) | 0.1 | $549k | 28k | 19.95 | |
| Neurogene (NGNE) | 0.1 | $526k | 30k | 17.33 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $499k | 65k | 7.74 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $488k | 122k | 4.00 | |
| Compugen Ord (CGEN) | 0.1 | $400k | 272k | 1.47 | |
| Sutro Biopharma (STRO) | 0.1 | $380k | 437k | 0.87 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $292k | 179k | 1.63 | |
| Biomx Com New (PHGE) | 0.1 | $211k | 401k | 0.53 | |
| Aprea Therapeutics Com New (APRE) | 0.0 | $202k | 137k | 1.48 |